ATNM ▲ +2.8% - Actinium Pharmaceuticals, Inc.
$ATNM ATNM ATNM - Actinium Pharmaceuticals Announces ASH 2026 Abstract Highlighting Long-Term Results of Actimab-A in Combination with CLAG-M in Relapsed or Refractory AML
04-NOV-2026 09:05 AM ET
Share this post
More filings for $ATNM
ATNM ▲ +2.8% - Actinium Pharmaceuticals, Inc.Nov 4, 2026ATNM ▼ -0.7% - Actinium Pharmaceuticals, Inc.Nov 2, 2026ATNM ▼ -3.3% - Actinium Pharmaceuticals, Inc.Oct 30, 2026ATNM ▲ +0.6% - Actinium Pharmaceuticals, Inc.Oct 23, 2026ATNM ▲ +3.0% - Actinium Pharmaceuticals, Inc.Oct 20, 2026ATNM ▲ +0.9% - Actinium Pharmaceuticals, Inc.Oct 19, 2026
View full $ATNM filing history →💬 Comments
Loading comments…
Leave a comment